(Q43286770)

English

Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group

scientific article published on 24 August 2009

Statements

Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group (English)
Hans-Helge Müller
Klaus-Jochen Klose
Behnaz Aminossadati
Ulrich-Frank Pape
Michael Bläker
Christian Arnold
PROMID Study Group

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit